Northeast Pharmaceutical Group Co., Ltd. (SHE:000597)

Market Cap	7.63B
Revenue (ttm)	7.51B
Net Income (ttm)	388.54M
Shares Out	1.43B
EPS (ttm)	0.27
PE Ratio	19.50
Forward PE	n/a
Dividend	0.10 (1.87%)
Ex-Dividend Date	May 23, 2024

Volume	11,282,000
Average Volume	19,074,279
Open	5.30
Previous Close	5.35
Day's Range	5.23 - 5.39
52-Week Range	3.72 - 6.69
Beta	0.30
RSI	46.22
Earnings Date	Aug 28, 2025

About SHE:000597

Northeast Pharmaceutical Group Co., Ltd. engages in chemical pharmaceuticals preparations, pharmaceutical business, pharmaceutical engineering, biomedicine, and other businesses in China. It offers vitamin products, including vitamin C, vitamin B1, vitamin B6, and levocarnitine series; anti-infection products, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other products; and reproductive system and sex hormone products comprising carboprost suppositories, carboprost tromethamine, dapoxetine hydroc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1946
• Employees: 5,964
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000597

Financial Performance

In 2024, SHE:000597's revenue was 7.50 billion, a decrease of -8.98% compared to the previous year's 8.24 billion. Earnings were 409.85 million, an increase of 14.34%.